← Leaderboards
Michael P Weiner
Abbratech, Inc.
$5,498,399
Attributed
$5,498,399
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$5,498,399 · 7
By mechanism
R44$4,610,349 · 4
R43$888,050 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Affinity”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,734,904
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$3,945,669
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
Research focus
AffinityProteinsAntibodiesBindingSiteSpecificityValidationTechnologyReagentPublishingInnovationCommercializationFlow CytometryFutureBiotechnologyKineticsCellsGenerationsAreaPhage DisplayBacteriophagesMeasurementMolecular BiologyEngineering
Grant awards (9)
A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D$1
R44 · FY2025 · GM · contact PI
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.$1,121,971
R44 · FY2024 · GM · contact PI
Platform for the High Throughput Generation and Validation of Affinity Reagents$1,080,240
R44 · FY2024 · GM · contact PI
DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE Abs$205,926
R44 · FY2024 · GM · contact PI
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.$1,121,971
R44 · FY2023 · GM · contact PI
Platform for the High Throughput Generation and Validation of Affinity Reagents$1,080,240
R44 · FY2023 · GM · contact PI
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy$295,460
R43 · FY2023 · GM · contact PI
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins. I. survey of existing antibodies, and II. development of method improvements$339,150
R43 · FY2022 · GM · contact PI
Method for the isolation of antibodies with functional activity against cell surface targets$253,440
R43 · FY2022 · AI · contact PI